Diabetic foot ulcer, antimicrobial remedies and emerging strategies for the treatment
An overview
Keywords:
DFUs, diabetes mellitus, antimicrobial peptides, diabetic neuropathy, biofilmsAbstract
According to the International Diabetes Federation's 2015 study, diabetes affects over 415 million people globally (5 million of whom die each year), and the incidence of diabetes is expected to climb to over 640 million (1 in 10) by 2040. (IDF 2015). Diabetes foot ulcers (DFU) are one of the most significant diabetic health consequences. Antimicrobial treatments, such as dressings, topical therapies, medicines, drugs, debridement procedures, molecular, cellular, and gene therapies, plant extracts, antimicrobial peptides, growth factors, devices, ozone, and energy-based therapies, would be the focus of this study. Scopus, Web of Science, Bentham Science, Science Direct, and Google Scholar were among the sources used to compile the English-language publications on DFU. DFU treatment requires a multidisciplinary approach that includes the use of proper diagnostic tools, competence, and experience. To prevent amputations, this starts with patient education and the use of new categories to steer treatment. New diagnostic methods, such as the 16S ribosomal DNA sequence in bacteria, should become available to acquire a better knowledge of the microbiota in DFUs.
Downloads
References
Jiménez PG, Martín-Carmona J, Hernández EL. Diabetes mellitus. Med. 2020;13(16):883–90. DOI: https://doi.org/10.1016/j.med.2020.09.010
Poretsky L. Principles of diabetes mellitus. Principles of Diabetes Mellitus. 2010. 1–887 p. DOI: https://doi.org/10.1007/978-0-387-09841-8
Aynalem SB, Zeleke AJ. Prevalence of Diabetes Mellitus and Its Risk Factors among Individuals Aged 15 Years and above in Mizan-Aman Town, Southwest Ethiopia, 2016: A Cross Sectional Study. Int J Endocrinol. 2018;2018. DOI: https://doi.org/10.1155/2018/9317987
Endris T, Worede A, Asmelash D. Prevalence of diabetes mellitus, prediabetes and its associated factors in dessie town, northeast ethiopia: A community-based study. Diabetes, Metab Syndr Obes Targets Ther. 2019;12:2799–809. DOI: https://doi.org/10.2147/DMSO.S225854
Nugroho PS, Tianingrum NA, Sunarti S, Rachman A, Fahrurodzi DS, Amiruddin R. Predictor risk of diabetes mellitus in Indonesia, based on national health survey. Vol. 16, Malaysian Journal of Medicine and Health Sciences. 2020. p. 126–30.
Hussain Z, Thu HE, Shuid AN, Katas H, Hussain F. Recent Advances in Polymer-based Wound Dressings for the Treatment of Diabetic Foot Ulcer: An Overview of State-of-the-art. Curr Drug Targets. 2017;19(5):527–50. DOI: https://doi.org/10.2174/1389450118666170704132523
Moura LIF, Dias AMA, Carvalho E, De Sousa HC. Recent advances on the development of wound dressings for diabetic foot ulcer treatment - A review. Vol. 9, Acta Biomaterialia. 2013. p. 7093–114. DOI: https://doi.org/10.1016/j.actbio.2013.03.033
Li WW, Li VW. Therapeutic angiogenesis for wound healing. In: Wounds. 2003.
Singh MR, Saraf S, Vyas A, Jain V, Singh D. Innovative approaches in wound healing: Trajectory and advances. Vol. 41, Artificial Cells, Nanomedicine and Biotechnology. 2013. p. 202–12. DOI: https://doi.org/10.3109/21691401.2012.716065
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. J Am Med Assoc. 2005;293(2):217–28. DOI: https://doi.org/10.1001/jama.293.2.217
MG R, J S. Diabetic Foot Infection, Biofilm & New Management Strategy. Diabetes Res Open Access. 2019;1(1):7–22. DOI: https://doi.org/10.36502/2019/droa.6152
Yazdanpanah L. Literature review on the management of diabetic foot ulcer. World J Diabetes. 2015;6(1):37. DOI: https://doi.org/10.4239/wjd.v6.i1.37
Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017;376(24):2367–75. DOI: https://doi.org/10.1056/NEJMra1615439
Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis†. Vol. 49, Annals of Medicine. 2017. p. 106–16. DOI: https://doi.org/10.1080/07853890.2016.1231932
Jeffcoate WJ, Vileikyte L, Boyko EJ, Armstrong DG, Boulton AJM. Current challenges and opportunities in the prevention and management of diabetic foot ulcers. Vol. 41, Diabetes Care. 2018. p. 645–52. DOI: https://doi.org/10.2337/dc17-1836
Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJM. A comparison of two diabetic foot ulcer classification systems: The Wagner and the University of Texas wound classification systems. Diabetes Care. 2001;24(1):84–8. DOI: https://doi.org/10.2337/diacare.24.1.84
Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21. DOI: https://doi.org/10.1016/j.diabres.2011.10.029
Eldor R, Raz I, Yehuda A Ben, Boulton AJM. New and experimental approaches to treatment of diabetic foot ulcers: A comprehensive review of emerging treatment strategies. Vol. 21, Diabetic Medicine. 2004. p. 1161–73. DOI: https://doi.org/10.1111/j.1464-5491.2004.01358.x
Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, et al. Diabetic foot ulcers: Part II. Management. Vol. 70, Journal of the American Academy of Dermatology. 2014. p. 21.e1-21.e24. DOI: https://doi.org/10.1016/j.jaad.2013.07.048
Management E, McCulloch JM, Kloth L, Kloth. Wound healing: evidence-based management. Contemporary Perspectives in Rehabilitation. 2010.
Muhammad Ibrahim A. Diabetic Foot Ulcer: Synopsis of the Epidemiology and Pathophysiology. Int J Diabetes Endocrinol. 2018;3(2):23. DOI: https://doi.org/10.11648/j.ijde.20180302.11
Rosyid FN. Etiology, pathophysiology, diagnosis and management of diabetics’ foot ulcer. Int J Res Med Sci. 2017;5(10):4206. DOI: https://doi.org/10.18203/2320-6012.ijrms20174548
Syafril S. Pathophysiology diabetic foot ulcer. In: IOP Conference Series: Earth and Environmental Science. 2018. DOI: https://doi.org/10.1088/1755-1315/125/1/012161
Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, et al. Diabetic foot ulcers: Part I. Pathophysiology and prevention. J Am Acad Dermatol. 2014;70(1):1.e1-1.e18. DOI: https://doi.org/10.1016/j.jaad.2013.06.055
Aumiller WD, Dollahite HA. Pathogenesis and management of diabetic foot ulcers. J Am Acad Physician Assist. 2015;28(5):28–34. DOI: https://doi.org/10.1097/01.JAA.0000464276.44117.b1
Alsanawi Y, Alismail H, AlabdRabalnabi M, Alturki H, Alsuhaibani A, Mahbub M, et al. Pathogenesis and management of diabetic foot ulcers. Int J Community Med Public Heal. 2018;5(11):4953. DOI: https://doi.org/10.18203/2394-6040.ijcmph20184249
Frykberg RG. Diabetic foot ulcers: Pathogenesis and management. Am Fam Physician. 2002;66(9):1655–62.
Megallaa MH, Ismail AA, Zeitoun MH, Khalifa MS. Association of diabetic foot ulcers with chronic vascular diabetic complications in patients with type 2 diabetes. Diabetes Metab Syndr Clin Res Rev. 2019;13(2):1287–92. DOI: https://doi.org/10.1016/j.dsx.2019.01.048
Esteghamati A, Aflatoonian M, Rad MV, Mazaheri T, Mousavizadeh M, Nakhjavani M, et al. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. Arch Cardiovasc Dis. 2015;108(8–9):412–9. DOI: https://doi.org/10.1016/j.acvd.2015.01.015
Muthiah A, Kandasamy R, S. N, Madasamy A. A study on diabetic foot and its association with peripheral artery disease. Int Surg J. 2017;4(4):1217. DOI: https://doi.org/10.18203/2349-2902.isj20170937
Schaper NC. Diabetic foot ulcer classification system for research purposes: A progress report on criteria for including patients in research studies. Diabetes Metab Res Rev. 2004;20(SUPPL. 1). DOI: https://doi.org/10.1002/dmrr.464
Loesche M, Gardner SE, Kalan L, Horwinski J, Zheng Q, Hodkinson BP, et al. Temporal Stability in Chronic Wound Microbiota Is Associated With Poor Healing. J Invest Dermatol. 2017;137(1):237–44. DOI: https://doi.org/10.1016/j.jid.2016.08.009
Andrea Nelson E, Backhouse MR, Bhogal MS, Wright-Hughes A, Lipsky BA, Nixon J, et al. Concordance in diabetic foot ulcer infection. BMJ Open. 2013;3(1). DOI: https://doi.org/10.1136/bmjopen-2012-002370
Nelson A, Wright-Hughes A, Backhouse MR, Lipsky BA, Nixon J, Bhogal MS, et al. CODIFI (Concordance in Diabetic Foot Ulcer Infection): A cross-sectional study of wound swab versus tissue sampling in infected diabetic foot ulcers in England. BMJ Open. 2018;8(1). DOI: https://doi.org/10.1136/bmjopen-2017-019437
Jouhar L, Jaafar RF, Nasreddine R, Itani O, Haddad F, Rizk N, et al. Microbiological profile and antimicrobial resistance among diabetic foot infections in Lebanon. Int Wound J. 2020;17(6):1764–73. DOI: https://doi.org/10.1111/iwj.13465
Jneid J, Lavigne JP, La Scola B, Cassir N. The diabetic foot microbiota: A review. Vols. 5–6, Human Microbiome Journal. 2017. p. 1–6. DOI: https://doi.org/10.1016/j.humic.2017.09.002
Pereira SG, Moura J, Carvalho E, Empadinhas N. Microbiota of chronic diabetic wounds: Ecology, impact, and potential for innovative treatment strategies. Vol. 8, Frontiers in Microbiology. 2017. DOI: https://doi.org/10.3389/fmicb.2017.01791
Martínez-De Jesús FR, Ramos-De La Medina A, Remes-Troche JM, Armstrong DG, Wu SC, Lázaro Martínez JL, et al. Efficacy and safety of neutral pH superoxidised solution in severe diabetic foot infections. Int Wound J. 2007;4(4):353–62. DOI: https://doi.org/10.1111/j.1742-481X.2007.00420_6.x
Liu PY, Shi ZY, Sheu WHH. Diagnosis and treatment of diabetic foot infections. J Intern Med Taiwan. 2012;23(6):431–41.
Miller AO, Henry M. Update in Diagnosis and Treatment of Diabetic Foot Infections. Vol. 20, Physical Medicine and Rehabilitation Clinics of North America. 2009. p. 611–25. DOI: https://doi.org/10.1016/j.pmr.2009.06.007
Murali TS, Kavitha S, Spoorthi J, Bhat D V., Prasad ASB, Upton Z, et al. Characteristics of microbial drug resistance and its correlates in chronic diabetic foot ulcer infections. J Med Microbiol. 2014;63:1377–85. DOI: https://doi.org/10.1099/jmm.0.076034-0
Jain S, Barman R. Bacteriological profile of diabetic foot ulcer with special reference to drug-resistant strains in a tertiary care center in North-East India. Indian J Endocrinol Metab. 2017;21(5):688–94. DOI: https://doi.org/10.4103/ijem.IJEM_546_16
Karmaker M, Sanyal SK, Sultana M, Hossain MA. Association of bacteria in diabetic and non-diabetic foot infection - An investigation in patients from Bangladesh. J Infect Public Health. 2016;9(3):267–77. DOI: https://doi.org/10.1016/j.jiph.2015.10.011
Smith K, Collier A, Townsend EM, O’Donnell LE, Bal AM, Butcher J, et al. One step closer to understanding the role of bacteria in diabetic foot ulcers: Characterising the microbiome of ulcers. BMC Microbiol. 2016;16(1). DOI: https://doi.org/10.1186/s12866-016-0665-z
Pouget C, Dunyach-Remy C, Pantel A, Schuldiner S, Sotto A, Lavigne JP. Biofilms in diabetic foot ulcers: Significance and clinical relevance. Vol. 8, Microorganisms. 2020. p. 1–15. DOI: https://doi.org/10.3390/microorganisms8101580
Donlan RM. Biofilms: Microbial life on surfaces. Emerg Infect Dis. 2002;8(9):881–90. DOI: https://doi.org/10.3201/eid0809.020063
Jain A, Gupta Y, Agrawal R, Khare P, Jain SK. Biofilms - A microbial life perspective: A critical review. Vol. 24, Critical Reviews in Therapeutic Drug Carrier Systems. 2007. p. 393–443. DOI: https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v24.i5.10
Bhinu VS. Insight into biofilm-associated microbial life. Vol. 10, Journal of Molecular Microbiology and Biotechnology. 2006. p. 15–21. DOI: https://doi.org/10.1159/000090344
Santos R, Veiga AS, Tavares L, Castanho M, Oliveira M. Bacterial Biofilms in Diabetic Foot Ulcers: Potential Alternative Therapeutics. In: Microbial Biofilms - Importance and Applications. 2016. DOI: https://doi.org/10.5772/63085
Messad N, Prajsnar TK, Lina G, O’Callaghan D, Foster SJ, Renshaw SA, et al. Existence of a colonizing Staphylococcus aureus strain isolated in diabetic foot ulcers. Diabetes. 2015;64(8):2991–5. DOI: https://doi.org/10.2337/db15-0031
Sharma D, Misba L, Khan AU. Antibiotics versus biofilm: An emerging battleground in microbial communities. Vol. 8, Antimicrobial Resistance and Infection Control. 2019. DOI: https://doi.org/10.1186/s13756-019-0533-3
Srivastava P, Sivashanmugam K. Combinatorial Drug Therapy for Controlling Pseudomonas aeruginosa and Its Association With Chronic Condition of Diabetic Foot Ulcer. Vol. 19, International Journal of Lower Extremity Wounds. 2020. p. 7–20. DOI: https://doi.org/10.1177/1534734619873785
Johani K, Malone M, Jensen S, Gosbell I, Dickson H, Hu H, et al. Microscopy visualisation confirms multi-species biofilms are ubiquitous in diabetic foot ulcers. Int Wound J. 2017;14(6):1160–9. DOI: https://doi.org/10.1111/iwj.12777
Shahi SK, Kumar A. Isolation and genetic analysis of multidrug resistant bacteria from diabetic foot ulcers. Front Microbiol. 2016;6(JAN). DOI: https://doi.org/10.3389/fmicb.2015.01464
Ji X, Jin P, Chu Y, Feng S, Wang P. Clinical characteristics and risk factors of diabetic foot ulcer with multidrug-resistant organism infection. Int J Low Extrem Wounds. 2014;13(1):64–71. DOI: https://doi.org/10.1177/1534734614521236
Zubair M, Malik A, Ahmad J. Clinico-bacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in north India. Biol Med. 2010;2(4):22–34.
Adeyemo AT, Kolawole B, Rotimi VO, Aboderin AO. Multicentre study of the burden of multidrug-resistant bacteria in the aetiology of infected diabetic foot ulcers. Afr J Lab Med. 2021;10(1). DOI: https://doi.org/10.4102/ajlm.v10i1.1261
Xie X, Bao Y, Ni L, Liu D, Niu S, Lin H, et al. Bacterial Profile and Antibiotic Resistance in Patients with Diabetic Foot Ulcer in Guangzhou, Southern China: Focus on the Differences among Different Wagner’s Grades, IDSA/IWGDF Grades, and Ulcer Types. Int J Endocrinol. 2017;2017. DOI: https://doi.org/10.1155/2017/8694903
Matta-Gutiérrez G, García-Morales E, García-Álvarez Y, Álvaro-Afonso FJ, Molines-Barroso RJ, Lázaro-Martínez JL. The Influence of Multidrug-Resistant Bacteria on Clinical Outcomes of Diabetic Foot Ulcers: A Systematic Review. J Clin Med. 2021;10(9):1948. DOI: https://doi.org/10.3390/jcm10091948
Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev. 2000;16(SUPPL. 1). DOI: https://doi.org/10.1002/1520-7560(200009/10)16:1+<::AID-DMRR139>3.0.CO;2-8
Balows A. Molecular Medical Microbiology. Diagn Microbiol Infect Dis. 2002;43(2):173–4. DOI: https://doi.org/10.1016/S0732-8893(02)00377-2
Tayeb KA. Managing infection: A holistic approach. J Wound Care. 2015;24(5):20–30. DOI: https://doi.org/10.12968/jowc.2015.24.Sup5b.20
Attinger C, Wolcott R. Clinically Addressing Biofilm in Chronic Wounds. Adv Wound Care. 2012;1(3):127–32. DOI: https://doi.org/10.1089/wound.2011.0333
Kataoka Y, Kunimitsu M, Nakagami G, Koudounas S, Weller CD, Sanada H. Effectiveness of ultrasonic debridement on reduction of bacteria and biofilm in patients with chronic wounds: A scoping review. Int Wound J. 2021;18(2):176–86. DOI: https://doi.org/10.1111/iwj.13509
Yarets Y. Effective biofilm removal and changes in bacterial biofilm building capacity after wound debridement with low-frequency ultrasound as part of wound bed preparation before skin grafting. Chronic Wound Care Manag Res. 2017;Volume 4:55–64. DOI: https://doi.org/10.2147/CWCMR.S127874
Dhar Y, Han Y. Current developments in biofilm treatments: Wound and implant infections. Eng Regen. 2020;1:64–75. DOI: https://doi.org/10.1016/j.engreg.2020.07.003
Wolcott R. Disrupting the biofilm matrix improves wound healing outcomes. J Wound Care. 2015;24(8):366–71. DOI: https://doi.org/10.12968/jowc.2015.24.8.366
Dreyfus J, Delhougne G, James R, Gayle J, Waycaster C. Clostridial collagenase ointment and medicinal honey utilization for pressure ulcers in US hospitals. J Med Econ. 2018;21(4):390–7. DOI: https://doi.org/10.1080/13696998.2017.1423489
Waycaster C, Carter MJ, Gilligan AM, Mearns ES, Fife CE, Milne CT. Comparative cost and clinical effectiveness of clostridial collagenase ointment for chronic dermal ulcers. Vol. 7, Journal of Comparative Effectiveness Research. 2018. p. 149–65. DOI: https://doi.org/10.2217/cer-2017-0066
Naomi R, Fauzi MB. Cellulose/collagen dressings for diabetic foot ulcer: A review. Vol. 12, Pharmaceutics. 2020. p. 1–18. DOI: https://doi.org/10.3390/pharmaceutics12090881
Zhang X, Sun D, Jiang GC. Comparative efficacy of nine different dressings in healing diabetic foot ulcer: A Bayesian network analysis. J Diabetes. 2019;11(6):418–26. DOI: https://doi.org/10.1111/1753-0407.12871
Dumville JC, Deshpande S, O’Meara S, Speak K. Hydrocolloid dressings for healing diabetic foot ulcers. Cochrane Database Syst Rev. 2013;2013(8). DOI: https://doi.org/10.1002/14651858.CD009099.pub3
Kwon KT, Armstrong DG. Microbiology and antimicrobial therapy for diabetic foot infections. Vol. 50, Infection and Chemotherapy. 2018. p. 11–20. DOI: https://doi.org/10.3947/ic.2018.50.1.11
Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): Prospective, randomised, controlled, double-blinded, multicentre trial. Lancet. 2005;366(9498):1695–703. DOI: https://doi.org/10.1016/S0140-6736(05)67694-5
Roberts AD, Simon GL. Diabetic foot infections: The role of microbiology and antibiotic treatment. Semin Vasc Surg. 2012;25(2):75–81. DOI: https://doi.org/10.1053/j.semvascsurg.2012.04.010
Karri VVSR, Kuppusamy G, Talluri SV, Yamjala K, Mannemala SS, Malayandi R. Current and emerging therapies in the management of diabetic foot ulcers. Vol. 32, Current Medical Research and Opinion. 2016. p. 519–42. DOI: https://doi.org/10.1185/03007995.2015.1128888
Ahmed A, Getti G, Boateng J. Ciprofloxacin-loaded calcium alginate wafers prepared by freeze-drying technique for potential healing of chronic diabetic foot ulcers. Drug Deliv Transl Res. 2018;8(6):1751–68. DOI: https://doi.org/10.1007/s13346-017-0445-9
Yingsakmongkol N. Clinical outcomes of WF10 adjunct to standard treatment of diabetic foot ulcers. J Wound Care. 2013;22(3):130–6. DOI: https://doi.org/10.12968/jowc.2013.22.3.130
Gasca-Lozano LE, Lucano-Landeros S, Ruiz-Mercado H, Salazar-Montes A, Sandoval-Rodríguez A, Garcia-Bañuelos J, et al. Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial. J Diabetes Res. 2017;2017:3159798. DOI: https://doi.org/10.1155/2017/3159798
Ram M, Singh V, Kumawat S, Kumar D, Lingaraju MC, Uttam Singh T, et al. Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats. Eur J Pharmacol. 2015;764:9–21. DOI: https://doi.org/10.1016/j.ejphar.2015.06.029
Maderal AD, Vivas AC, Eaglstein WH, Kirsner RS. The FDA and designing clinical trials for chronic cutaneous ulcers. Vol. 23, Seminars in Cell and Developmental Biology. 2012. p. 993–9. DOI: https://doi.org/10.1016/j.semcdb.2012.09.014
Tecilazich F, Dinh TL, Veves A. Emerging drugs for the treatment of diabetic ulcers. Vol. 18, Expert Opinion on Emerging Drugs. 2013. p. 207–17. DOI: https://doi.org/10.1517/14728214.2013.802305
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
